연구성과로 돌아가기
2023 연구자 정보 (66 / 1135)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Author Name | 제1저자 여부 | 교신저자 여부 | Address | ResearcherID | ORCID | Paper Title | WoS Edition | 최상위 JCR(%) | WoS Category | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
|
Reig, Maria (Reig, M) |
|
|
[JCR상위 1.7] Outcomes by occurrence of immune-mediated adverse events (imAEs) with tremelimumab (T) plus durvalumab (D) in the phase 3 HIMALAYA study in unresectable hepatocellular carcinoma (uHCC) | SCIE | 1.7 | ONCOLOGY | ||||
|
Rha, Sun Young (Rha, SY) |
|
|
[JCR상위 1.7] ATTRACTION-5: A phase 3 study of nivolumab plus chemotherapy as postoperative adjuvant treatment for pathological stage III (pStage III) gastric or gastroesophageal junction (G/GEJ) cancer | SCIE | 1.7 | ONCOLOGY | ||||
|
Ryoo, Baek-Yeol (Ryoo, BY) |
Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, 88 Olymp Ro,43 Gil, Seoul 05505, South Korea |
|
|
[JCR상위 1.7] Serum vitamin D3 levels and overall survival (OS) in patients (pts) with advanced biliary tract cancer (BTC): Analysis of the NIFTY trial cohort. [JCR상위 3.6] Treatment With Liposomal Irinotecan Plus Fluorouracil and Leucovorin for Patients With Previously Treated Metastatic Biliary Tract Cancer The Phase 2b NIFTY Randomized Clinical Trial |
SCIE | 1.7 | ONCOLOGY | yooc@amc.seoul.kr; | ||
|
Ryu, Ho Jin (Ryu, HJ) |
Korea Adv Inst Sci & Technol KAIST, Dept Nucl & Quantum Engn, 291 Daehak Ro, Daejeon 34141, South Korea |
|
|
[JCR상위 1.7] Enhanced thermoelectric properties of NbCoSn half-Heuslers through in-situ nanocrystallization of amorphous precursors during the consolidation process | SCIE | 1.7 | MATERIALS SCIENCE, MULTIDISCIPLINARY;METALLURGY & METALLURGICAL ENGINEERING | yish@knu.ac.kr;p.choi@kaist.ac.kr; | ||
|
Ryu, Hyewon (Ryu, H) |
Chungnam Natl Univ, Chungnam Natl Univ Hosp, Dept Internal Med, Div Hematol & Oncol,Coll Med, Daejeon, South Korea |
|
|
[JCR상위 1.7] Serum vitamin D3 levels and overall survival (OS) in patients (pts) with advanced biliary tract cancer (BTC): Analysis of the NIFTY trial cohort. [JCR상위 3.6] Treatment With Liposomal Irinotecan Plus Fluorouracil and Leucovorin for Patients With Previously Treated Metastatic Biliary Tract Cancer The Phase 2b NIFTY Randomized Clinical Trial |
SCIE | 1.7 | ONCOLOGY | yooc@amc.seoul.kr; | ||
|
Ryu, Keun Won (Ryu, KW) |
|
|
[JCR상위 1.7] ATTRACTION-5: A phase 3 study of nivolumab plus chemotherapy as postoperative adjuvant treatment for pathological stage III (pStage III) gastric or gastroesophageal junction (G/GEJ) cancer | SCIE | 1.7 | ONCOLOGY | ||||
|
Ryu, Min-Hee (Ryu, MH) |
|
|
[JCR상위 1.7] ATTRACTION-5: A phase 3 study of nivolumab plus chemotherapy as postoperative adjuvant treatment for pathological stage III (pStage III) gastric or gastroesophageal junction (G/GEJ) cancer | SCIE | 1.7 | ONCOLOGY | ||||
|
Sagalova, Olga (Sagalova, O) |
South Ural State Med Univ, Chelyabinsk, Russia |
HJI-1475-2023 Sagalova, Olga |
0000-0003-3814-7342 Sagalova, Olga |
[JCR상위 1.7] Evidence of durable response to bepirovirsen in B-Clear responders: B-Sure first annual report | SCIE | 1.7 | GASTROENTEROLOGY & HEPATOLOGY | robert.c.elston@gsk.com; | ||
|
Sakuramoto, Shinichi (Sakuramoto, S) |
|
|
[JCR상위 1.7] ATTRACTION-5: A phase 3 study of nivolumab plus chemotherapy as postoperative adjuvant treatment for pathological stage III (pStage III) gastric or gastroesophageal junction (G/GEJ) cancer | SCIE | 1.7 | ONCOLOGY | ||||
|
Sangro, Bruno (Sangro, B) |
AFW-4106-2022 Sangro, Bruno |
|
[JCR상위 1.7] Outcomes by occurrence of immune-mediated adverse events (imAEs) with tremelimumab (T) plus durvalumab (D) in the phase 3 HIMALAYA study in unresectable hepatocellular carcinoma (uHCC) | SCIE | 1.7 | ONCOLOGY | ||||
|
Sasako, Mitsuru (Sasako, M) |
|
|
[JCR상위 1.7] ATTRACTION-5: A phase 3 study of nivolumab plus chemotherapy as postoperative adjuvant treatment for pathological stage III (pStage III) gastric or gastroesophageal junction (G/GEJ) cancer | SCIE | 1.7 | ONCOLOGY | ||||
|
Schellenberg, Samuel (Schellenberg, S) |
|
|
[JCR상위 1.7] Post-double lung transplantation survival outcomes of bilateral lung cancer and incidence of post-transplant lung cancer | SCIE | 1.7 | ONCOLOGY | ||||
|
Schwabe, Christian (Schwabe, C) |
New Zealand Clin Res, Auckland, New Zealand |
|
|
[JCR상위 1.7] A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitis | SCIE | 1.7 | GASTROENTEROLOGY & HEPATOLOGY | mfyuen@hku.hk; | ||
|
Scott, Russell (Scott, R) |
New Zealand Clin Res, Lipid & Diabet Res, Christchurch, New Zealand |
|
0000-0002-2107-6480 Scott, Russell |
[JCR상위 1.7] A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitis | SCIE | 1.7 | GASTROENTEROLOGY & HEPATOLOGY | mfyuen@hku.hk; | ||
|
Serfaty, Lawrence (Serfaty, L) |
HUS Hop Hautepierre, Strasbourg, France |
GQP-1022-2022 DEBACK, Claire |
|
[JCR상위 1.7] Evidence of durable response to bepirovirsen in B-Clear responders: B-Sure first annual report | SCIE | 1.7 | GASTROENTEROLOGY & HEPATOLOGY | robert.c.elston@gsk.com; |
페이지 이동: